Regional and national differences in stroke thrombolysis use and disparities in pricing, treatment availability, and coverage

BACKGROUND: Major disparities have been reported in recombinant tissue plasminogen activator (rtPA) availability among countries of different socioeconomic status. - AIMS: To characterize variability of rtPA price, its availability, and its association with and impact on each country's health e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Souza, Ana Claudia de (VerfasserIn) , Sebastian, Ivy Anne (VerfasserIn) , Zaidi, Wan Asyraf Wan (VerfasserIn) , Nasreldein, Ahmed (VerfasserIn) , Bazadona, Danira (VerfasserIn) , Amaya, Pablo (VerfasserIn) , Elkady, Ahmed (VerfasserIn) , Gebrewold, Meron Awraris (VerfasserIn) , Vorasayan, Pongpat (VerfasserIn) , Yeghiazaryan, Nune (VerfasserIn) , Michel, Patrik (VerfasserIn) , Khatri, Pooja (VerfasserIn) , Pandian, Jeyaraj Durai (VerfasserIn) , Martins, Sheila Cristina Ouriques (VerfasserIn) , Hacke, Werner (VerfasserIn) , Lioutas, Vasileios-Arsenios (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2022
In: International journal of stroke
Year: 2022, Jahrgang: 17, Heft: 9, Pages: 990-996
ISSN:1747-4949
DOI:10.1177/17474930221082446
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1177/17474930221082446
Verlag, Volltext: https://journals.sagepub.com/doi/10.1177/17474930221082446
Volltext
Verfasserangaben:Ana Claudia de Souza, Ivy Anne Sebastian, Wan Asyraf Wan Zaidi, Ahmed Nasreldein, Danira Bazadona, Pablo Amaya, Ahmed Elkady, Meron Awraris Gebrewold, Pongpat Vorasayan, Nune Yeghiazaryan, Patrik Michel, Pooja Khatri, Jeyaraj Durai Pandian, Sheila Cristina Ouriques Martins, Werner Hacke, and Vasileios-Arsenios Lioutas

MARC

LEADER 00000caa a2200000 c 4500
001 1822268494
003 DE-627
005 20230426192554.0
007 cr uuu---uuuuu
008 221114s2022 xx |||||o 00| ||eng c
024 7 |a 10.1177/17474930221082446  |2 doi 
035 |a (DE-627)1822268494 
035 |a (DE-599)KXP1822268494 
035 |a (OCoLC)1361693035 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Souza, Ana Claudia de  |e VerfasserIn  |0 (DE-588)1272725448  |0 (DE-627)1822269741  |4 aut 
245 1 0 |a Regional and national differences in stroke thrombolysis use and disparities in pricing, treatment availability, and coverage  |c Ana Claudia de Souza, Ivy Anne Sebastian, Wan Asyraf Wan Zaidi, Ahmed Nasreldein, Danira Bazadona, Pablo Amaya, Ahmed Elkady, Meron Awraris Gebrewold, Pongpat Vorasayan, Nune Yeghiazaryan, Patrik Michel, Pooja Khatri, Jeyaraj Durai Pandian, Sheila Cristina Ouriques Martins, Werner Hacke, and Vasileios-Arsenios Lioutas 
264 1 |c 2022 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First published: February 9, 2022 
500 |a Gesehen am 14.11.2022 
520 |a BACKGROUND: Major disparities have been reported in recombinant tissue plasminogen activator (rtPA) availability among countries of different socioeconomic status. - AIMS: To characterize variability of rtPA price, its availability, and its association with and impact on each country's health expenditure (HE) resources. - METHODS: We conducted a global survey to obtain information on rtPA price (50 mg vial, 2020 US Dollars) and availability. Country-specific data, including low, lower middle (LMIC), upper middle (UMIC), and high-income country (HIC) classifications, and gross domestic product (GDP) and HE, both nominally and adjusted for purchasing power parity (PPP), were obtained from World Bank Open Data. To assess the impact of rtPA cost, we computed the rtPA price as percentage of per capita GDP and HE and examined its association with the country income classification. - RESULTS: rtPA is approved and available in 109 countries. We received surveys from 59 countries: 27 (46%) HIC, 20 (34%) UMIC, and 12 (20%) LMIC. Although HIC have significantly higher per capita GDP and HE compared to UMIC and LMIC (p < 0.0001), the median price of rtPA is non-significantly higher in LMICs (USD 755, interquartile range, IQR (575-1300)) compared to UMICs (USD 544, IQR (400-815)) and HICs (USD 600, IQR (526-1000)). In LMIC, rtPA cost accounts for 217.4% (IQR, 27.1-340.6%) of PPP-adjusted per capita HE, compared to 17.6% (IQR (11.2-28.7%), p < 0.0001) for HICs. - CONCLUSION: We documented significant variability in rtPA availability and price among countries. Relative costs are higher in lower income countries, exceeding the available HE. Concerted efforts to improve rtPA affordability in low-income settings are necessary. 
650 4 |a availability 
650 4 |a Costs and Cost Analysis 
650 4 |a drug cost 
650 4 |a Gross Domestic Product 
650 4 |a Humans 
650 4 |a Ischemic stroke 
650 4 |a rtPA 
650 4 |a Stroke 
650 4 |a thrombolysis 
650 4 |a Thrombolytic Therapy 
650 4 |a Tissue Plasminogen Activator 
700 1 |a Sebastian, Ivy Anne  |e VerfasserIn  |4 aut 
700 1 |a Zaidi, Wan Asyraf Wan  |e VerfasserIn  |4 aut 
700 1 |a Nasreldein, Ahmed  |e VerfasserIn  |4 aut 
700 1 |a Bazadona, Danira  |e VerfasserIn  |4 aut 
700 1 |a Amaya, Pablo  |e VerfasserIn  |4 aut 
700 1 |a Elkady, Ahmed  |e VerfasserIn  |4 aut 
700 1 |a Gebrewold, Meron Awraris  |e VerfasserIn  |4 aut 
700 1 |a Vorasayan, Pongpat  |e VerfasserIn  |4 aut 
700 1 |a Yeghiazaryan, Nune  |e VerfasserIn  |4 aut 
700 1 |a Michel, Patrik  |e VerfasserIn  |4 aut 
700 1 |a Khatri, Pooja  |e VerfasserIn  |4 aut 
700 1 |a Pandian, Jeyaraj Durai  |e VerfasserIn  |4 aut 
700 1 |a Martins, Sheila Cristina Ouriques  |e VerfasserIn  |4 aut 
700 1 |a Hacke, Werner  |d 1948-  |e VerfasserIn  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 aut 
700 1 |a Lioutas, Vasileios-Arsenios  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t International journal of stroke  |d London : Sage, 2005  |g 17(2022), 9, Seite 990-996  |h Online-Ressource  |w (DE-627)503720291  |w (DE-600)2211666-7  |w (DE-576)306832739  |x 1747-4949  |7 nnas  |a Regional and national differences in stroke thrombolysis use and disparities in pricing, treatment availability, and coverage 
773 1 8 |g volume:17  |g year:2022  |g number:9  |g pages:990-996  |g extent:7  |a Regional and national differences in stroke thrombolysis use and disparities in pricing, treatment availability, and coverage 
856 4 0 |u https://doi.org/10.1177/17474930221082446  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.sagepub.com/doi/10.1177/17474930221082446  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20221114 
993 |a Article 
994 |a 2022 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 50000  |e 50000PH12021699X  |k 0/50000/  |p 15 
999 |a KXP-PPN1822268494  |e 4210272558 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1822268494","id":{"doi":["10.1177/17474930221082446"],"eki":["1822268494"]},"language":["eng"],"physDesc":[{"extent":"7 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["First published: February 9, 2022","Gesehen am 14.11.2022"],"person":[{"family":"Souza","display":"Souza, Ana Claudia de","roleDisplay":"VerfasserIn","given":"Ana Claudia de","role":"aut"},{"display":"Sebastian, Ivy Anne","family":"Sebastian","roleDisplay":"VerfasserIn","role":"aut","given":"Ivy Anne"},{"given":"Wan Asyraf Wan","role":"aut","roleDisplay":"VerfasserIn","display":"Zaidi, Wan Asyraf Wan","family":"Zaidi"},{"role":"aut","given":"Ahmed","roleDisplay":"VerfasserIn","display":"Nasreldein, Ahmed","family":"Nasreldein"},{"role":"aut","given":"Danira","roleDisplay":"VerfasserIn","family":"Bazadona","display":"Bazadona, Danira"},{"family":"Amaya","display":"Amaya, Pablo","roleDisplay":"VerfasserIn","given":"Pablo","role":"aut"},{"given":"Ahmed","role":"aut","roleDisplay":"VerfasserIn","display":"Elkady, Ahmed","family":"Elkady"},{"role":"aut","given":"Meron Awraris","display":"Gebrewold, Meron Awraris","family":"Gebrewold","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Pongpat","family":"Vorasayan","display":"Vorasayan, Pongpat","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Nune","display":"Yeghiazaryan, Nune","family":"Yeghiazaryan","roleDisplay":"VerfasserIn"},{"family":"Michel","display":"Michel, Patrik","roleDisplay":"VerfasserIn","role":"aut","given":"Patrik"},{"given":"Pooja","role":"aut","display":"Khatri, Pooja","family":"Khatri","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Jeyaraj Durai","display":"Pandian, Jeyaraj Durai","family":"Pandian","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Sheila Cristina Ouriques","display":"Martins, Sheila Cristina Ouriques","family":"Martins","roleDisplay":"VerfasserIn"},{"family":"Hacke","display":"Hacke, Werner","roleDisplay":"VerfasserIn","given":"Werner","role":"aut"},{"given":"Vasileios-Arsenios","role":"aut","family":"Lioutas","display":"Lioutas, Vasileios-Arsenios","roleDisplay":"VerfasserIn"}],"title":[{"title":"Regional and national differences in stroke thrombolysis use and disparities in pricing, treatment availability, and coverage","title_sort":"Regional and national differences in stroke thrombolysis use and disparities in pricing, treatment availability, and coverage"}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"2022"}],"name":{"displayForm":["Ana Claudia de Souza, Ivy Anne Sebastian, Wan Asyraf Wan Zaidi, Ahmed Nasreldein, Danira Bazadona, Pablo Amaya, Ahmed Elkady, Meron Awraris Gebrewold, Pongpat Vorasayan, Nune Yeghiazaryan, Patrik Michel, Pooja Khatri, Jeyaraj Durai Pandian, Sheila Cristina Ouriques Martins, Werner Hacke, and Vasileios-Arsenios Lioutas"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"id":{"issn":["1747-4949"],"zdb":["2211666-7"],"eki":["503720291"],"doi":["10.1111/(ISSN)1747-4949"]},"titleAlt":[{"title":"official journal of the International Stroke Society"}],"recId":"503720291","title":[{"title_sort":"International journal of stroke","subtitle":"official journal of the World Stroke Organization","title":"International journal of stroke"}],"note":["Gesehen am 10.02.2021"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Regional and national differences in stroke thrombolysis use and disparities in pricing, treatment availability, and coverageInternational journal of stroke","pubHistory":["Volume 1, issue 1 (February 2006)-"],"origin":[{"publisherPlace":"London ; Oxford [u.a.] ; Oxford [u.a.]","dateIssuedDisp":"21 November 2005-","publisher":"Sage ; Blackwell ; Wiley-Blackwell"}],"part":{"year":"2022","issue":"9","extent":"7","text":"17(2022), 9, Seite 990-996","volume":"17","pages":"990-996"}}]} 
SRT |a SOUZAANACLREGIONALAN2022